The important role of myeloid-derived suppressor cells: From hepatitis to liver cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-07 · 1880 (3) · 189329
DOI: 10.1016/j.bbcan.2025.189329 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-07. Verfasst von Siwen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji H…. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Liver Neoplasms, Carcinoma, Hepatocellular, Hepatitis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hubei Province Natural Science Foundation, National Natural Science Foundation of China, Huazhong University of Science and Technology.
Abstract (Originalsprache)
Liver homeostasis is coordinated by crosstalk between resident and infiltrating inflammatory cells. Liver disease creates a dynamic inflammatory microenvironment characterized by aberrant metabolism and continuous hepatic regeneration, making it an important risk factor for hepatocellular carcinoma (HCC) as well as liver failure. Recent studies have revealed a critical heterogeneous population of myeloid-derived suppressor cells (MDSCs), which influence liver disease progression and malignancy by dynamically regulating the immune microenvironment. MDSCs play an important role in preventing excessive immune responses in the liver. However, MDSCs are also associated with the promotion of liver injury and liver cancer progression. The plasticity of MDSCs in liver disease is a unique challenge for therapeutic intervention strategies and requires a deeper understanding of the underlying mechanisms. Here, we review the role of MDSCs in the establishment and progression of liver disease and highlight the evidence for MDSCs as a priority target for current and future therapeutic strategies. We explore the fate of MDSCs from hepatitis to liver cancer, providing recent insights into potential targets for clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and…
- Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Clinical Medicine Research Center for Hepatic Su…
Förderung
- Hubei Province Natural Science Foundation
- National Natural Science Foundation of China
- Huazhong University of Science and Technology
Zitieren
APA
Li, S., Zhang, J., Wei, W., Zhang, Z., Huang, W., & Xia, L. (2025). The important role of myeloid-derived suppressor cells: From hepatitis to liver cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(3), 189329. https://doi.org/10.1016/j.bbcan.2025.189329
Vancouver
Li S, Zhang J, Wei W, Zhang Z, Huang W, Xia L. The important role of myeloid-derived suppressor cells: From hepatitis to liver cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(3):189329. doi:10.1016/j.bbcan.2025.189329
BibTeX
@article{Li2025,
author = {Li, Siwen and Zhang, Jiaqian and Wei, Wang and Zhang, Zhicheng and Huang, Wenjie and Xia, Limin},
title = {The important role of myeloid-derived suppressor cells: From hepatitis to liver cancer},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {3},
pages = {189329},
doi = {10.1016/j.bbcan.2025.189329}
}
EUVIMED